Join US
Partner with us

U.S. Department of Defense Critical Reagents Program

With the support of the U.S. Department of Defense’s Critical Reagents Program, Fondation Mérieux USA and Penn State University have assessed whether five World Health Organization (WHO) Emerging and Dangerous Pathogens Laboratory Network (EDPLN) laboratories have the staff and resources necessary to support the introduction of the Global Bio Technology Initiative (GBTI) - including the MagPix, Illumina MiSeq and Applied Biosystems 7500 - and evaluated the benefits to the host nation of sustainable technologies for pathogen discovery.

The WHO’s EDPLN brings together high security human and veterinary diagnostic laboratories that work together to enhance response to emerging pathogens and improve diagnostic readiness. In order to meet these coals, the EDPLN labs share samples, knowledge, and research results with one another, and also enable the transfer of diagnostics and training throughout their national and regional networks. EDPLN laboratories are also members of the Global Outbreak Alert and Response Network (GOARN), which brings laboratories and scientists together to share best practices and tools for combatting the emergence and mitigating the impacts of dangerous pathogens.

The project conducted evaluations at five WHO EDPLN locations in Africa:

  1. The International Center for Medical Research (CIRMF) in Gabon
  2. The Uganda Virus Research Institute (UVRI)
  3. The National Institute of Communicable Diseases (NICD) in South Africa
  4. Institut National de Recherche Biomédical (INRB) in the Democratic Republic of the Congo
  5. Institut Pasteur laboratory in Senegal

Top of Page